Moreover, ITAM mutants could calibrate CD28-based CAR-T cells’ activation, through which CAR-T cells can be guided to various fates, allowing a CD28-based CAR-T cell with mutations in ITAM1 and ITAM2 domains to maintain long-lasting memory but retain efficient anti-tumor function [125]. Here, CD28 is linked to neoplasm.